Wearable that reads aortic stenosis
A new chest‑worn biosensor can detect aortic stenosis and even grade disease severity — a step beyond step‑counts and sleep metrics toward clinical cardiac screening. (medscape.com). The device suggests wearables are moving from lifestyle tracking into potential medical‑grade triage tools. (medscape.com)
The peer‑reviewed report of the chest‑worn, multimodal biosensor appeared on ScienceDirect in March 2026 and was summarized by Medscape on March 27, 2026. (sciencedirect.com)) Study authors said the device records multiple chest signals and "accurately measures aortic valve acceleration time (AT)" and uses those signals to predict peak aortic valve velocity (AV Vmax). (sciencedirect.com)) The paper’s authors presented predictive AV Vmax estimates as a way to grade valve stenosis severity and argued the approach supports lower‑cost, accessible tools for early detection and longitudinal monitoring of aortic stenosis. (sciencedirect.com)) That claim builds on existing seismocardiography research: a deep‑learning SCG study found wearable SCG recordings produced Vmax estimates in good agreement with same‑day 4D‑flow MRI in a 77‑subject cohort. (link.springer.com)) A recent systematic review of chest‑worn sensors noted that, to date, none of the chest‑strap devices studied have formal CE or FDA approval for clinical use, highlighting the need for larger, regulatory‑facing validation before deployment as a triage tool. (mdpi.com)) Medscape’s coverage positioned the device as evidence that wearables are moving beyond consumer metrics toward clinical screening applications, while the ScienceDirect article framed the work as feasibility data rather than an immediately deployable clinical device. (medscape.com))
